Status: Recruiting
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
This study will evaluate two human amnion/chorion membrane (ppLHACM) products and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs).
Participants needed: 170
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: MiMedx Group, Inc.Updated: Sep 19, 2024Locations: 1
Eligibility criteria
At least 18 years of age or older. [+10]
Target ulcers located on the plantar aspect of the foot must be offloaded for at... [+26]